ALPS Advisors’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $324K | Sell |
17,366
-6,318
| -27% | -$118K | ﹤0.01% | 910 |
|
|
2025
Q1 | $430K | Sell |
23,684
-248
| -1% | -$4.5K | ﹤0.01% | 612 |
|
|
2024
Q4 | $522K | Buy |
23,932
+1,635
| +7% | +$35.6K | ﹤0.01% | 596 |
|
|
2024
Q3 | $610K | Sell |
22,297
-618
| -3% | -$16.9K | ﹤0.01% | 587 |
|
|
2024
Q2 | $593K | Buy |
+22,915
| New | +$593K | ﹤0.01% | 554 |
|
|
2022
Q2 | – | Sell |
-3,777
| Closed | -$175K | – | 1049 |
|
|
2022
Q1 | $175K | Sell |
3,777
-474
| -11% | -$22K | ﹤0.01% | 810 |
|
|
2021
Q4 | $301K | Sell |
4,251
-235
| -5% | -$16.6K | ﹤0.01% | 831 |
|
|
2021
Q3 | $523K | Buy |
4,486
+484
| +12% | +$56.4K | 0.01% | 491 |
|
|
2021
Q2 | $626K | Sell |
4,002
-1,488
| -27% | -$233K | 0.01% | 489 |
|
|
2021
Q1 | $1.04M | Buy |
5,490
+39
| +0.7% | +$7.39K | 0.01% | 395 |
|
|
2020
Q4 | $684K | Buy |
5,451
+1,605
| +42% | +$201K | 0.01% | 435 |
|
|
2020
Q3 | $418K | Buy |
3,846
+480
| +14% | +$52.2K | 0.01% | 484 |
|
|
2020
Q2 | $405K | Buy |
+3,366
| New | +$405K | 0.01% | 481 |
|
|
2019
Q4 | – | Sell |
-4,833
| Closed | -$793K | – | 826 |
|
|
2019
Q3 | $793K | Sell |
4,833
-209
| -4% | -$34.3K | 0.01% | 346 |
|
|
2019
Q2 | $1.19M | Buy |
+5,042
| New | +$1.19M | 0.01% | 291 |
|